💨 Abstract

Eli Lilly plans to introduce its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, and Mexico by 2026. The drug, already approved in China, aims to serve approximately 900 million patients worldwide, as global demand for such treatments has surged. The company is scaling up supply before entering new markets.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖